Ligand Reiterates 2025 Guidance of $225M to $235M in Core Revenue
Ligand will reiterate its 2025 guidance outlined in November: Total core revenue of $225 million to $235 million comprised of $147 million to $157 million in royalty revenue, $40 million in Captisol sales, and $38 million in core contract revenue; Core adjusted earnings per diluted share of $7.40 to $7.65. Revenue consensus $263.77M.
